News
Stay informed with our latest news posts.
Yazen Health closes €19.5M series A to drive global growth
Yazen Health has successfully closed an oversubscribed €19.5 million series A funding round to fuel its international expansion. This investment enables Yazen to enhance its pioneering obesity treatment model, combining modern weight loss medication with comprehensive lifestyle support.
Sifted UK: Yazen raises €19.5m to expand obesity treatment in the EU
Yazen has secured €19.5 million in Series A funding to expand its GLP-1-based obesity treatment across Europe. The company combines medication with lifestyle support for sustainable weight loss results.
Lasker~DeBakey Award 2024 for groundbreaking GLP-1 obesity research
Lasker~DeBakey Award 2024 for groundbreaking GLP-1 obesity research
Startups shifting to GLP-1s to tap into $150bn weight loss market
GLP-1 weight loss drugs like Wegovy are attracting startups and investors, aiming to tap into the projected $150bn market despite supply and reimbursement challenges
The urgent need for strict warnings on ultra-processed foods
Four foods that should come with a smoking-style health warning Some scientists believe ultra-processed food needs to be treated in a similar way to tobacco.
Yazen and Dr Martin Carlsson in Health Tech World
Join Health Tech World's webinar with experts discussing sustainable weight loss through medication, lifestyle changes, and digital health tools. Watch now!
Popular drug linked to reduced dementia risk in elderly with diabetes
Study shows GLP-1 agonists reduce dementia risk in elderly with type 2 diabetes. Findings from KI highlight potential benefits for diabetes treatment
WHO: Medical Product Alert: Fake Ozempic (semaglutide)
Medical Product Alert: Fake Ozempic (semaglutide) Detected in Americas and Europe
Wigan named UK's 'Fattest Town' - Yazen Health tackles obesity safely
Wigan named UK's 'Fattest Town' - Yazen Health tackles obesity safely
Dr. Punam Krishan debunks myths surrounding obesity
Dr. Punam Krishan debunks myths surrounding obesity
What care do the morbidly obese individuals need?
The obesity epidemic is one of the greatest health challenges of our time. Globally, it is estimated that 1.9 billion people will suffer from morbid obesity by 2035, which represents one in four adults. Among children, obesity is expected to increase by 100 percent between 2020 and 2035. The cost to society is projected to be 4 trillion dollars.
Yazen participates in roundtable with Health Tech World
Martin Carlsson participates in "Where next for digital health? A roundtable debate hosted by Health Tech World
Yazen transforms the accessibility of obesity treatment
Yazen tackles the challenge with groundbreaking, accessible, and comprehensive treatment approach
Shortages and concerns arise as weight-loss injections gain popularity
Weight-loss injections like Ozempic and Wegovy have gained significant attention, European startups entering market
Yazen's weight control success: 60 tonnes shed!
Patients at the digital healthcare provider Yazen have now collectively shed 60 tonnes
There are no results with this criteria. Try changing your search.
.webp)
